Clinical Trials Directory

Trials / Completed

CompletedNCT05164159

The Comparison of Hemodynamic Effects Between Remimazolam-remifentanil and Propofol-remifentanil in Patients Undergoing Laparoscopic Cholecystectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
274 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
19 Years – 90 Years
Healthy volunteers
Accepted

Summary

This study is conducted to determine whether the occurrence of hypotension is reduced by the combined use of remimazolam and remifentanil compared to the conventional combination use of propofol and remifentanil. Patients enrolled in the study are infused continuously with either propofol or remimazolam from the start of anesthesia to the end of surgery.

Conditions

Interventions

TypeNameDescription
DRUGpropofol groupDuring induction, the propofol group starts the effect site concentration at 4.0 ng/ml with TCI and adjusts it to around 3.0 \~ 4.0 ng/ml after intubation to maintain an appropriate EEG-based depth of anesthesia.
DRUGremimazolam groupIn the remimazolam group, start remimazolam at 6 mg/kg/hr and adjust it to 1 mg/kg/hr after loss of consciousness to maintain an appropriate EEG-based depth of anesthesia.

Timeline

Start date
2022-02-20
Primary completion
2022-08-22
Completion
2022-08-22
First posted
2021-12-20
Last updated
2022-11-07

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05164159. Inclusion in this directory is not an endorsement.